Abstract
Evangelos Tsianakas, Seval Kul, Fiona Nafaa, Koray Durak, Pedro López‐Ayala, Emel Kaplan, Gabrielle Huré, Alexander Ritz, Luca Koechlin, Ivo Strebel, Philip Haaf, Simon Frey, Felix Mahfoud, Michael T. Zellweger, Christian Mueller
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Epidemiology of coronary artery disease
10.1016/j.suc.2022.01.007 · 2022
Acute coronary syndromes: mechanisms, challenges, and new opportunities
10.1093/eurheartj/ehaf289 · 2025
Permanent work disability in patients ≤50 years old after percutaneous coronary intervention and coronary artery bypass grafting (the CRAGS study)
10.1093/ehjqcco/qcw043 · 2016
Heart disease and stroke statistics—2021 update: a report from the American Heart Association
10.1161/cir.0000000000000950 · 2021
Economic burden of cardiovascular diseases in the European Union: a population-based cost study
10.1093/eurheartj/ehad583 · 2023
ESC guidelines for the management of chronic coronary syndromes
10.1093/eurheartj/ehae177 · 2024
Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing
10.1016/j.jacc.2012.11.056 · 2013
Temporal trends in pretest probability and normal scan rates in myocardial perfusion imaging: a 24-year experience from a Swiss tertiary referral center (between 2000 and 2024)
10.1093/ehjci/jeag076 · 2026
Physician decision making and trends in the use of cardiac stress testing in the United States: an analysis of repeated cross-sectional data
10.7326/m14-0296 · 2014
Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD)
10.1007/s00392-022-01992-6 · 2022
Soluble urokinase plasminogen activator receptor and functionally relevant coronary artery disease: a prospective cohort study
10.1080/1354750x.2022.2038269 · 2022
Diagnostic and prognostic value of H-ficolin for functionally relevant coronary artery disease
10.1016/j.cca.2023.117582 · 2023
Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomes
10.1080/1354750x.2023.2172211 · 2023
Using high-sensitivity cardiac troponin for the exclusion of inducible myocardial ischemia in symptomatic patients: a cohort study
10.7326/m19-0080 · 2020
Direct comparison of cardiac troponin T and I using a uniform and a sex-specific approach in the detection of functionally relevant coronary artery disease
10.1373/clinchem.2018.286971 · 2018
Incremental value of heart-type fatty acid-binding protein in suspected acute myocardial infarction early after symptom onset
2016
Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction
10.1136/heartjnl-2012-303325 · 2013
Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man
10.1007/bf01270583 · 1992
Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction
10.1016/0009-9120(91)90571-u · 1991
Use of a whole blood rapid panel test for heart-type fatty acid–binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests
10.1016/s0002-9343(03)00325-5 · 2003
Clinical benefit of high-sensitivity cardiac troponin I in the detection of exercise-induced myocardial ischemia
10.1016/j.ahj.2015.11.010 · 2016
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach
10.2307/2531595 · 1988
Dealing with continuous variables and modelling non-linear associations in healthcare data: practical guide
10.1136/bmj-2024-082440 · 2025
MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS
10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4 · 1996
Unresolved referenced work
Kept as external metadata until matched
Growth differentiation factor-15 in patients presenting with acute chest pain: diagnostic and prognostic utility
10.1016/j.ejim.2025.106694 · 2026
Introduction to the analysis of survival data in the presence of competing risks
10.1161/circulationaha.115.017719 · 2016
Clinical utility of circulating interleukin-6 concentrations in the detection of functionally relevant coronary artery disease
10.1016/j.ijcard.2018.10.029 · 2019
Diagnostic and prognostic value of mannan-binding lectin associated protein (MAp19) for functionally relevant coronary artery disease
10.1016/j.cca.2024.119668 · 2024
Direct comparison of cardiac troponin I and cardiac troponin T in the detection of exercise-induced myocardial ischemia
10.1016/j.clinbiochem.2015.12.005 · 2016
Incremental value of a single high-sensitivity cardiac troponin I measurement to rule out myocardial ischemia
10.1016/j.amjmed.2015.01.009 · 2015
Incremental value of a single high-sensitivity cardiac troponin I measurement to rule out myocardial ischemia
10.1016/j.amjmed.2015.01.009 · doi-reference
Direct comparison of cardiac troponin I and cardiac troponin T in the detection of exercise-induced myocardial ischemia
10.1016/j.clinbiochem.2015.12.005 · doi-reference
Diagnostic and prognostic value of mannan-binding lectin associated protein (MAp19) for functionally relevant coronary artery disease
10.1016/j.cca.2024.119668 · doi-reference
Clinical utility of circulating interleukin-6 concentrations in the detection of functionally relevant coronary artery disease
10.1016/j.ijcard.2018.10.029 · doi-reference
Introduction to the analysis of survival data in the presence of competing risks
10.1161/circulationaha.115.017719 · doi-reference
Growth differentiation factor-15 in patients presenting with acute chest pain: diagnostic and prognostic utility
10.1016/j.ejim.2025.106694 · doi-reference
MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS
10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4 · doi-reference
Dealing with continuous variables and modelling non-linear associations in healthcare data: practical guide
10.1136/bmj-2024-082440 · doi-reference
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach
10.2307/2531595 · doi-reference
Clinical benefit of high-sensitivity cardiac troponin I in the detection of exercise-induced myocardial ischemia
10.1016/j.ahj.2015.11.010 · doi-reference
Use of a whole blood rapid panel test for heart-type fatty acid–binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests
10.1016/s0002-9343(03)00325-5 · doi-reference
Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction
10.1016/0009-9120(91)90571-u · doi-reference
Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man
10.1007/bf01270583 · doi-reference
Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction
10.1136/heartjnl-2012-303325 · doi-reference
Direct comparison of cardiac troponin T and I using a uniform and a sex-specific approach in the detection of functionally relevant coronary artery disease
10.1373/clinchem.2018.286971 · doi-reference
Using high-sensitivity cardiac troponin for the exclusion of inducible myocardial ischemia in symptomatic patients: a cohort study
10.7326/m19-0080 · doi-reference
Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomes
10.1080/1354750x.2023.2172211 · doi-reference
Diagnostic and prognostic value of H-ficolin for functionally relevant coronary artery disease
10.1016/j.cca.2023.117582 · doi-reference
Soluble urokinase plasminogen activator receptor and functionally relevant coronary artery disease: a prospective cohort study
10.1080/1354750x.2022.2038269 · doi-reference
Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD)
10.1007/s00392-022-01992-6 · doi-reference
Physician decision making and trends in the use of cardiac stress testing in the United States: an analysis of repeated cross-sectional data
10.7326/m14-0296 · doi-reference
Temporal trends in pretest probability and normal scan rates in myocardial perfusion imaging: a 24-year experience from a Swiss tertiary referral center (between 2000 and 2024)
10.1093/ehjci/jeag076 · doi-reference
Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing
10.1016/j.jacc.2012.11.056 · doi-reference
ESC guidelines for the management of chronic coronary syndromes
10.1093/eurheartj/ehae177 · doi-reference
Economic burden of cardiovascular diseases in the European Union: a population-based cost study
10.1093/eurheartj/ehad583 · doi-reference
Heart disease and stroke statistics—2021 update: a report from the American Heart Association
10.1161/cir.0000000000000950 · doi-reference
Permanent work disability in patients ≤50 years old after percutaneous coronary intervention and coronary artery bypass grafting (the CRAGS study)
10.1093/ehjqcco/qcw043 · doi-reference
Acute coronary syndromes: mechanisms, challenges, and new opportunities
10.1093/eurheartj/ehaf289 · doi-reference
Epidemiology of coronary artery disease
10.1016/j.suc.2022.01.007 · doi-reference